Member Exclusive

Japanese Pharmaceutical & Medical Devices Agency

As part of its Japanese partnering strategy, RepliCel seeks advice of Japanese regulators around its fibroblast platform

Go to the profile of Lee Buckler
Mar 23, 2015
0
0

Please sign in or register for FREE

Register to RegMedNet – the regenerative medicine network

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.

Register

No comments yet.